Dr Jane Latimer is a Professor in the School of Public Health at the University of Sydney, and Deputy Director of the Institute for Musculoskeletal Health. She is Visiting Professor at Oxford University in the Nuffield Department of Orthopaedics and Rheumatology. Musculoskeletal conditions affect over 6.8 million Australians and are the leading cause of disability in Australia. Jane’s work has focused on changing this by designing and leading high quality clinical trials to identify the most effective treatments. These trials have been some of the most challenging and influential in the field including placebo controlled trials of surgery and trials of opioid medication where there is significant potential for harm. She has received over $22m to fund her work and has published in the world’s leading medical journals including New England Journal of Medicine, Lancet and Nature.
Jane also works as Director of Strategy for Elizabeth Broderick & Co., an organisation focused on gender equality and cultural change. In this role she works closely with the STEM Champions of Change coalition and supports Elizabeth Broderick in her role as UN Chair-Rapporteur for Discrimination against women and girls. She has been an invited mentor for both University and Industry programs and recognises the responsibility a good mentor has to move beyond advice and coaching and to use their positional power to advance the careers of mentees.